These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15893373)

  • 1. Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogs.
    Gentilini F; Calzolari C; Turba ME; Agnoli C; Fava D; Forni M; Bergamini PF
    Leuk Res; 2005 Nov; 29(11):1263-9. PubMed ID: 15893373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
    Laack E; Scheffler A; Burkholder I; Boeters I; Andritzky B; Schuch G; Görn M; Vohwinkel G; Edler L; Fiedler W; Hossfeld DK
    Lung Cancer; 2005 Oct; 50(1):51-8. PubMed ID: 15992959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals.
    Randeva HS; Lewandowski KC; Komorowski J; Murray RD; O'Callaghan CJ; Hillhouse EW; Stepien H; Shalet SM
    Circulation; 2004 May; 109(20):2405-10. PubMed ID: 15123527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gelatinases (MMP-2 and MMP-9), TIMP-1, vascular endothelial growth factor (VEGF), and microvessel density on the clinicopathological behavior of childhood non-Hodgkin lymphoma.
    Citak EC; Oguz A; Karadeniz C; Akyurek N
    Pediatr Hematol Oncol; 2008; 25(1):55-66. PubMed ID: 18231955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF and MMP-9: biomarkers for canine lymphoma.
    Aresu L; Aricò A; Comazzi S; Gelain ME; Riondato F; Mortarino M; Morello E; Stefanello D; Castagnaro M
    Vet Comp Oncol; 2014 Mar; 12(1):29-36. PubMed ID: 22489798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer.
    Quaranta M; Daniele A; Coviello M; Venneri MT; Abbate I; Caringella ME; Di Tardo S; Divella R; Trerotoli P; Di Gennaro M; Schittulli F; Fransvea E; Giannelli G
    Anticancer Res; 2007; 27(5B):3593-600. PubMed ID: 17972522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
    Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
    Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
    Alexandrakis MG; Sfiridaki A; Miyakis S; Pappa C; Kandidaki E; Alegakis A; Margioris AN
    Clin Chim Acta; 2007 Apr; 379(1-2):31-5. PubMed ID: 17234170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma level and prognostic significance of VEGF, bFGF and MMP-9 in patients with advanced non-small-cell lung cancer].
    Zhao J; Liu XY; Zhang QY; Jiang W
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):676-9. PubMed ID: 16438890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vascular endothelial growth factor (VEGF) is elevated in GH deficient adults.
    Murray RD; Randeva HS; Lewandowski KC; Komorowski J; Lawrance JA; Adams JE; Shalet SM
    Growth Horm IGF Res; 2011 Apr; 21(2):96-101. PubMed ID: 21450501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
    Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of proangiogenic cytokines in children with lymphomas.
    Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
    Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphoma.
    Citak EC; Oguz A; Karadeniz C; Akyurek N
    Pathol Res Pract; 2008; 204(2):89-96. PubMed ID: 18207652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into molecular mechanisms of diffuse coronary ectasiae: a possible role for VEGF.
    Savino M; Parisi Q; Biondi-Zoccai GG; Pristipino C; Cianflone D; Crea F
    Int J Cardiol; 2006 Jan; 106(3):307-12. PubMed ID: 16337037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
    Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
    Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcoma.
    Thamm DH; O'Brien MG; Vail DM
    Vet Comp Oncol; 2008 Jun; 6(2):126-32. PubMed ID: 19178672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
    Yildiz B; Kural N; Colak O; Ak I; Akcar N
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression.
    Kim SH; Cho NH; Kim K; Lee JS; Koo BS; Kim JH; Chang JH; Choi EC
    J Surg Oncol; 2006 Mar; 93(4):330-7. PubMed ID: 16496371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.